Primary Site >> Pancreatic Cancer
Gene >> GCG
| 1. | |||||||||||
| Journal: | J Clin Endocrinol Metab. 1985 Sep;61(3):472-9. | ||||||||||
| Title: | Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas. | ||||||||||
| Author: | Uttenthal, L O|Ghiglione, M|George, S K|Bishop, A E|Polak, J M|Bloom, S R | ||||||||||
| PMID: | 2991321 | ||||||||||
| 2. | |||||||||||
| Journal: | Mol Endocrinol. 1992 Dec;6(12):2175-84. | ||||||||||
| Title: | Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagon-producing GLUTag transplantable tumor. | ||||||||||
| Author: | Drucker, D J|Lee, Y C|Asa, S L|Brubaker, P L | ||||||||||
| PMID: | 1491697 | ||||||||||
| 3. | |||||||||||
| Journal: | Diabetes Res Clin Pract. 1994 Aug;25(1):43-9. | ||||||||||
| Title: | Glucagon-like peptide-1 (GLP-1) molecular forms in human pancreatic endocrine tumors resemble those in intestine rather than pancreas. | ||||||||||
| Author: | Tateishi, K|Shima, K|Funakoshi, A|Yasunami, Y|Iwamoto, N|Matsuoka, Y | ||||||||||
| PMID: | 7835211 | ||||||||||
| 4. | |||||||||||
| Journal: | Anticancer Res. 1996 Nov-Dec;16(6B):3761-6. | ||||||||||
| Title: | Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor. | ||||||||||
| Author: | Hrascan, R|Pavelic, K|Pavicic, D|Krizanac, S|Stajcer-Sittic, V|Pecur, L|Spaventi, S|Klimpfinger, M|Pavelic, J | ||||||||||
| PMID: | 9042254 | ||||||||||
| 5. | |||||||||||
| Journal: | Diabetes. 1999 Dec;48(12):2358-66. | ||||||||||
| Title: | Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. | ||||||||||
| Author: | Zhou, J|Wang, X|Pineyro, M A|Egan, J M | ||||||||||
| PMID: | 10580424 | ||||||||||
| 6. | |||||||||||
| Journal: | J Nucl Med. 2006 Dec;47(12):2025-33. | ||||||||||
| Title: | [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. | ||||||||||
| Author: | Wild, Damian|Behe, Martin|Wicki, Andreas|Storch, Daniel|Waser, Beatrice|Gotthardt, Martin|Keil, Boris|Christofori, Gerhard|Reubi, Jean Claude|Macke, Helmut R | ||||||||||
| PMID: | 17138746 | ||||||||||
| 7. | |||||||||||
| Journal: | Carcinogenesis. 2010 Apr;31(4):666-70. | ||||||||||
| Title: | Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic. | ||||||||||
| Author: | Naccarati, A|Pardini, B|Polakova, V|Smerhovsky, Z|Vodickova, L|Soucek, P|Vrana, D|Holcatova, I|Ryska, M|Vodicka, P | ||||||||||
| PMID: | 20110284 | ||||||||||
| 8. | |||||||||||
| Journal: | Gastroenterology. 2010 Jun;138(7):2519-30. | ||||||||||
| Title: | Differentiation of pancreatic acinar cells to hepatocytes requires an intermediate cell type. | ||||||||||
| Author: | Wu, Sung-Yu|Hsieh, Chi-Che|Wu, Ruei-Ren|Susanto, Jimmy|Liu, Tsung-Ta|Shen, Chia-Rui|Chen, Yu|Su, Chien-Chang|Chang, Fang-Pei|Chang, Hsiao-Min|Tosh, David|Shen, Chia-Ning | ||||||||||
| PMID: | 20178796 | ||||||||||
| 9. | |||||||||||
| Journal: | Life Sci. 2011 Jan 31;88(5-6):218-25. | ||||||||||
| Title: | Identification of serum proteins involved in pancreatic cancer cachexia. | ||||||||||
| Author: | Felix, Klaus|Fakelman, Frederik|Hartmann, Daniel|Giese, Nathalia A|Gaida, Matthias M|Schnolzer, Martina|Flad, Thomas|Buchler, Markus W|Werner, Jens | ||||||||||
| PMID: | 21094171 | ||||||||||
| 10. | |||||||||||
| Journal: | Gastroenterology. 2011 Jul;141(1):150-6. | ||||||||||
| Title: | Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. | ||||||||||
| Author: | Elashoff, Michael|Matveyenko, Aleksey V|Gier, Belinda|Elashoff, Robert|Butler, Peter C | ||||||||||
| PMID: | 21334333 | ||||||||||
| 11. | |||||||||||
| Journal: | Diabetes Metab Res Rev. 2011 Sep;27(6):528-42. | ||||||||||
| Title: | The safety and tolerability of GLP-1 receptor agonists in the treatment of type 2 diabetes: a review. | ||||||||||
| Author: | Aroda, Vanita R|Ratner, Robert | ||||||||||
| PMID: | 21484979 | ||||||||||
| 12. | |||||||||||
| Journal: | J Nucl Med. 2011 Jul;52(7):1073-8. | ||||||||||
| Title: | Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. | ||||||||||
| Author: | Wild, Damian|Christ, Emanuel|Caplin, Martyn E|Kurzawinski, Tom R|Forrer, Flavio|Brandle, Michael|Seufert, Jochen|Weber, Wolfgang A|Bomanji, Jamshed|Perren, Aurel|Ell, Peter J|Reubi, Jean Claude | ||||||||||
| PMID: | 21680696 | ||||||||||
| 13. | |||||||||||
| Journal: | J Virol. 2011 Dec;85(23):12759-68. | ||||||||||
| Title: | A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice. | ||||||||||
| Author: | Dan, Meixia|Chantler, Janet K | ||||||||||
| PMID: | 21937637 | ||||||||||
| 14. | |||||||||||
| Journal: | Int J Oncol. 2012 Jan;40(1):40-6. | ||||||||||
| Title: | Dickkopf-3 maintains the PANC-1 human pancreatic tumor cells in a dedifferentiated state. | ||||||||||
| Author: | Zenzmaier, Christoph|Hermann, Martin|Hengster, Paul|Berger, Peter | ||||||||||
| PMID: | 21879258 | ||||||||||
| 15. | |||||||||||
| Journal: | Endocr Relat Cancer. 2012 Sep 5;19(5):F77-88. | ||||||||||
| Title: | GLP1 and cancer: friend or foe? | ||||||||||
| Author: | Vangoitsenhoven, Roman|Mathieu, Chantal|Van der Schueren, Bart | ||||||||||
| PMID: | 22691625 | ||||||||||
| 16. | |||||||||||
| Journal: | Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):463-73. | ||||||||||
| Title: | 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma. | ||||||||||
| Author: | Kiesewetter, Dale O|Gao, Haokao|Ma, Ying|Niu, Gang|Quan, Qimeng|Guo, Ning|Chen, Xiaoyuan | ||||||||||
| PMID: | 22170321 | ||||||||||
| 17. | |||||||||||
| Journal: | Eur J Intern Med. 2013 Apr;24(3):207-12. | ||||||||||
| Title: | Incretin-based therapies in the treatment of type 2 diabetes--more than meets the eye? | ||||||||||
| Author: | Labuzek, Krzysztof|Kozlowski, Michal|Szkudlapski, Dawid|Sikorska, Patrycja|Kozlowska, Monika|Okopien, Boguslaw | ||||||||||
| PMID: | 23375875 | ||||||||||
| 18. | |||||||||||
| Journal: | JAMA Intern Med. 2013 Apr 8;173(7):534-9. | ||||||||||
| Title: | Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. | ||||||||||
| Author: | Singh, Sonal|Chang, Hsien-Yen|Richards, Thomas M|Weiner, Jonathan P|Clark, Jeanne M|Segal, Jodi B | ||||||||||
| PMID: | 23440284 | ||||||||||
| 19. | |||||||||||
| Journal: | Diabetes Care. 2013 Jul;36(7):2126-32. | ||||||||||
| Title: | A critical analysis of the clinical use of incretin-based therapies: The benefits by far outweigh the potential risks. | ||||||||||
| Author: | Nauck, Michael A | ||||||||||
| PMID: | 23645884 | ||||||||||
| 20. | |||||||||||
| Journal: | Diabetes Care. 2013 Jul;36(7):2118-25. | ||||||||||
| Title: | A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe? | ||||||||||
| Author: | Butler, Peter C|Elashoff, Michael|Elashoff, Robert|Gale, Edwin A M | ||||||||||
| PMID: | 23645885 | ||||||||||
| 21. | |||||||||||
| Journal: | Diabet Med. 2013 Oct;30(10):1148-55. | ||||||||||
| Title: | The potential risks of pancreatitis and pancreatic cancer with GLP-1-based therapies are far outweighed by the proven and potential (cardiovascular) benefits. | ||||||||||
| Author: | Ryder, R E J | ||||||||||
| PMID: | 24073725 | ||||||||||
| 22. | |||||||||||
| Journal: | Rev Diabet Stud. 2014 Fall-Winter;11(3-4):202-30. | ||||||||||
| Title: | Adverse Effects of GLP-1 Receptor Agonists. | ||||||||||
| Author: | Filippatos, Theodosios D|Panagiotopoulou, Thalia V|Elisaf, Moses S | ||||||||||
| PMID: | 26177483 | ||||||||||
| 23. | |||||||||||
| Journal: | Pancreas. 2014 Jan;43(1):1-6. | ||||||||||
| Title: | Expression of glucagon-like Peptide 1 receptor and its effects on biologic behavior in pancreatic neuroendocrine tumors. | ||||||||||
| Author: | Cases, Ana Ines|Ohtsuka, Takao|Fujino, Minoru|Ideno, Noboru|Kozono, Shingo|Zhao, Ming|Ohuchida, Kenoki|Aishima, Shinichi|Nomura, Masatoshi|Oda, Yoshinao|Mizumoto, Kazuhiro|Tanaka, Masao | ||||||||||
| PMID: | 24326362 | ||||||||||
| 24. | |||||||||||
| Journal: | Drug Saf. 2014 Dec;37(12):1003-10. | ||||||||||
| Title: | Balancing benefits and risks in patients receiving incretin-based therapies: focus on cardiovascular and pancreatic side effects. | ||||||||||
| Author: | Haluzik, Martin|Mraz, Milos|Svacina, Stepan | ||||||||||
| PMID: | 25391858 | ||||||||||
| 25. | |||||||||||
| Journal: | Curr Med Res Opin. 2014 Dec;30(12):2471-81. | ||||||||||
| Title: | Incretin-mimetic therapies and pancreatic disease: a review of observational data. | ||||||||||
| Author: | Suarez, Elizabeth A|Koro, Carol E|Christian, Jennifer B|Spector, Alicia D|Araujo, Andre B|Abraham, Sybil | ||||||||||
| PMID: | 25180611 | ||||||||||
| 26. | |||||||||||
| Journal: | Nucl Med Biol. 2014 Jul;41(6):471-6. | ||||||||||
| Title: | Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma. | ||||||||||
| Author: | Selvaraju, Ram Kumar|Velikyan, Irina|Asplund, Veronika|Johansson, Lars|Wu, Zhanhong|Todorov, Ivan|Shively, Jack|Kandeel, Fouad|Eriksson, Barbro|Korsgren, Olle|Eriksson, Olof | ||||||||||
| PMID: | 24857864 | ||||||||||
| 27. | |||||||||||
| Journal: | Diabetes Obes Metab. 2014 Sep;16(9):850-60. | ||||||||||
| Title: | Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway. | ||||||||||
| Author: | Zhao, H|Wang, L|Wei, R|Xiu, D|Tao, M|Ke, J|Liu, Y|Yang, J|Hong, T | ||||||||||
| PMID: | 24641303 | ||||||||||
| 28. | |||||||||||
| Journal: | Drugs. 2014 Feb;74(2):223-42. | ||||||||||
| Title: | Sitagliptin: a review of its use in patients with type 2 diabetes mellitus. | ||||||||||
| Author: | Plosker, Greg L | ||||||||||
| PMID: | 24407560 | ||||||||||
| 29. | |||||||||||
| Journal: | Diabetes. 2014 Apr;63(4):1303-14. | ||||||||||
| Title: | Occurrence of spontaneous pancreatic lesions in normal and diabetic rats: a potential confounding factor in the nonclinical assessment of GLP-1-based therapies. | ||||||||||
| Author: | Chadwick, Kristina D|Fletcher, Anthony M|Parrula, M Cecilia|Bonner-Weir, Susan|Mangipudy, Raja S|Janovitz, Evan|Graziano, Michael J|Roy, Denis|Reilly, Timothy P | ||||||||||
| PMID: | 24222349 | ||||||||||
| 30. | |||||||||||
| Journal: | Am J Physiol Endocrinol Metab. 2014 Jun 15;306(12):E1431-41. | ||||||||||
| Title: | Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner. | ||||||||||
| Author: | Zhao, Hejun|Wei, Rui|Wang, Liang|Tian, Qing|Tao, Ming|Ke, Jing|Liu, Ye|Hou, Wenfang|Zhang, Lin|Yang, Jin|Hong, Tianpei | ||||||||||
| PMID: | 24801389 | ||||||||||
| 31. | |||||||||||
| Journal: | Expert Opin Drug Saf. 2015 Jan;14(1):171-80. | ||||||||||
| Title: | Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancer. | ||||||||||
| Author: | Chalmer, Thor|Almdal, Thomas P|Vilsboll, Tina|Knop, Filip K | ||||||||||
| PMID: | 25363438 | ||||||||||
| 32. | |||||||||||
| Journal: | PLoS One. 2015 Jul 20;10(7):e0133812. | ||||||||||
| Title: | Pancreatic Neuroendocrine Tumors in Mice Deficient in Proglucagon-Derived Peptides. | ||||||||||
| Author: | Takano, Yuko|Kasai, Kenji|Takagishi, Yoshiko|Kikumori, Toyone|Imai, Tsuneo|Murata, Yoshiharu|Hayashi, Yoshitaka | ||||||||||
| PMID: | 26192435 | ||||||||||
| 33. | |||||||||||
| Journal: | Oncol Rep. 2015 Oct;34(4):1717-25. | ||||||||||
| Title: | Significance of expression of glucagon-like peptide 1 receptor in pancreatic cancer. | ||||||||||
| Author: | Cases, Ana Ines|Ohtsuka, Takao|Kimura, Hideyo|Zheng, Biao|Shindo, Koji|Oda, Yoshinao|Mizumoto, Kazuhiro|Nakamura, Masafumi|Tanaka, Masao | ||||||||||
| PMID: | 26238361 | ||||||||||
| 34. | |||||||||||
| Journal: | Int J Cardiol. 2016 Jan 1;202:731-5. | ||||||||||
| Title: | The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy. | ||||||||||
| Author: | Sportiello, Liberata|Rafaniello, Concetta|Scavone, Cristina|Vitale, Cristiana|Rossi, Francesco|Capuano, Annalisa | ||||||||||
| PMID: | 26461922 | ||||||||||
| 35. | |||||||||||
| Journal: | Pancreatology. 2016 Jan-Feb;16(1):2-7. | ||||||||||
| Title: | GLP-1 mimetic drugs and the risk of exocrine pancreatic disease: Cell and animal studies. | ||||||||||
| Author: | Williams, John A | ||||||||||
| PMID: | 26751948 | ||||||||||
| 36. | |||||||||||
| Journal: | Pancreatology. 2017 Jan - Feb;17(1):89-94. | ||||||||||
| Title: | Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss. | ||||||||||
| Author: | Skrha, Jan|Busek, Petr|Uhrova, Jana|Hrabal, Petr|Kmochova, Klara|Laclav, Martin|Bunganic, Bohus|Fric, Premysl | ||||||||||
| PMID: | 28027898 | ||||||||||
| 37. | |||||||||||
| Journal: | Lancet Diabetes Endocrinol. 2017 May;5(5):355-366. | ||||||||||
| Title: | Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, mul | ||||||||||
| Author: | Aroda, Vanita R|Bain, Stephen C|Cariou, Bertrand|Piletic, Milivoj|Rose, Ludger|Axelsen, Mads|Rowe, Everton|DeVries, J Hans | ||||||||||
| PMID: | 28344112 | ||||||||||
| 38. | |||||||||||
| Journal: | Cardiovasc Diabetol. 2017 Mar 1;16(1):31. | ||||||||||
| Title: | Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes. | ||||||||||
| Author: | Zhang, Zeqing|Chen, Xi|Lu, Puhan|Zhang, Jianhua|Xu, Yongping|He, Wentao|Li, Mengni|Zhang, Shujun|Jia, Jing|Shao, Shiying|Xie, Junhui|Yang, Yan|Yu, Xuefeng | ||||||||||
| PMID: | 28249585 | ||||||||||
| 39. | |||||||||||
| Journal: | Lancet Diabetes Endocrinol. 2018 Feb;6(2):105-113. | ||||||||||
| Title: | Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis. | ||||||||||
| Author: | Bethel, M Angelyn|Patel, Rishi A|Merrill, Peter|Lokhnygina, Yuliya|Buse, John B|Mentz, Robert J|Pagidipati, Neha J|Chan, Juliana C|Gustavson, Stephanie M|Iqbal, Nayyar|Maggioni, Aldo P|Ohman, Peter|Poulter, Neil R|Ramachandran, Ambady|Zinman, Bernard|Hern | ||||||||||
| PMID: | 29221659 | ||||||||||
| 40. | |||||||||||
| Journal: | Cancer Lett. 2018 Sep 1;431:190-200. | ||||||||||
| Title: | Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1cells in vitro by down-regulating the PCSK1/3. | ||||||||||
| Author: | Zhang, Yuefeng|Huang, Shifei|Li, Pengping|Chen, Qing|Li, Yongzhou|Zhou, Yizhao|Wang, Lantian|Kang, Muxing|Zhang, Bo|Yang, Bin|Dong, Xin|Wu, Yulian | ||||||||||
| PMID: | 29800682 | ||||||||||
| 41. | |||||||||||
| Journal: | J Clin Endocrinol Metab. 2018 Apr 1;103(4):1296-1301. | ||||||||||
| Title: | Recent Topics Around Multiple Endocrine Neoplasia Type 1. | ||||||||||
| Author: | Marx, Stephen J | ||||||||||
| PMID: | 29897580 | ||||||||||
| 42. | |||||||||||
| Journal: | Diabetes. 2018 Sep;67(9):1710-1719. | ||||||||||
| Title: | The Ascending GLP-1 Road From Clinical Safety to Reduction of Cardiovascular Complications. | ||||||||||
| Author: | Drucker, Daniel J | ||||||||||
| PMID: | 30135132 | ||||||||||
| 43. | |||||||||||
| Journal: | Cochrane Database Syst Rev. 2018 Sep 24;9:CD011798. | ||||||||||
| Title: | Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. | ||||||||||
| Author: | Lo, Clement|Toyama, Tadashi|Wang, Ying|Lin, Jin|Hirakawa, Yoichiro|Jun, Min|Cass, Alan|Hawley, Carmel M|Pilmore, Helen|Badve, Sunil V|Perkovic, Vlado|Zoungas, Sophia | ||||||||||
| PMID: | 30246878 | ||||||||||
| 44. | |||||||||||
| Journal: | Front Pharmacol. 2018 Sep 21;9:1071. | ||||||||||
| Title: | Cucurbitacin B Induces Hypoglycemic Effect in Diabetic Mice by Regulation of AMP-Activated Protein Kinase Alpha and Glucagon-Like Peptide-1 via Bitter Taste Receptor Signaling. | ||||||||||
| Author: | Kim, Kang-Hoon|Lee, In-Seung|Park, Ji Young|Kim, Yumi|An, Eun-Jin|Jang, Hyeung-Jin | ||||||||||
| PMID: | 30298009 | ||||||||||